Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Research and Markets: Dermatitis - Pipeline Review, H1 2012

Research and Markets
Posted on: 11 Apr 12

Research and Markets (http://www.researchandmarkets.com/research/2d9aaf13/dermatitis_pipel) has announced the addition of Global Markets Direct's new report "Dermatitis - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Dermatitis - Pipeline Review, H1 2012', provides an overview of the Dermatitis therapeutic pipeline. This report provides information on the therapeutic development for Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dermatitis. 'Dermatitis - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Key Topics Covered:

  • Introduction
  • Global Markets Direct Report Coverage
  • Dermatitis Overview
  • Therapeutics Development
  • An Overview of Pipeline Products for Dermatitis
  • Dermatitis Therapeutics under Development by Companies
  • Dermatitis Therapeutics under Investigation by Universities/Institutes
  • Late Stage Products
  • Comparative Analysis
  • Mid Clinical Stage Products
  • Comparative Analysis
  • Early Clinical Stage Products
  • Comparative Analysis
  • Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Dermatitis Therapeutics - Products under Development by Companies
  • Dermatitis Therapeutics - Products under Investigation by Universities/Institutes
  • Companies Involved in Dermatitis Therapeutics Development
  • Dermatitis - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Drug Profiles
  • Dermatitis Therapeutics - Drug Profile Updates
  • Dermatitis Therapeutics - Discontinued Products
  • Dermatitis Therapeutics - Dormant Products
  • Dermatitis - Product Development Milestones
  • Featured News & Press Releases
  • Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation
  • Contact Us
  • Disclaimer

Companies Mentioned:

  • Johnson & Johnson
  • Bayer HealthCare AG
  • Amgen Inc.
  • GlaxoSmithKline plc
  • Daiichi Sankyo Company, Ltd
  • Novartis AG
  • Dong-A Pharmaceutical Co., Ltd.
  • Eisai Co., Ltd.
  • Galderma S.A.
  • LEO Pharma A/S
  • Manhattan Pharmaceuticals, Inc.
  • Almirall, S.A.
  • Basilea Pharmaceutica Ltd.
  • NicOx SA
  • Nuvo Research Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Hanall Pharmaceutical Co., Ltd.
  • AnGes MG, Inc.
  • Biotie Therapies Corp.
  • Provectus Pharmaceuticals, Inc.
  • Summit Corporation plc
  • Proximagen Neuroscience plc.
  • R-Tech Ueno, Ltd.
  • Fougera
  • Paloma Pharmaceuticals, Inc.
  • Asubio Pharmaceuticals, Inc.
  • Palau Pharma S.A
  • Respiratorius AB
  • MIKA Pharma GmbH
  • CREABILIS Therapeutics S.r.l.
  • Anacor Pharmaceuticals, Inc.
  • JADO Technologies GmbH.
  • IMMD Inc.
  • Circassia Holdings Ltd.
  • Hawthorn Pharmaceuticals, Inc.
  • Oxagen Limited
  • Melior Discovery, Inc.
  • NovImmune SA
  • SARcode Corporation
  • Welichem Biotech Inc.
  • Cutanea Life Sciences
  • Action Pharma A/S
  • SWITCH Biotech LLC
  • Aerovance, Inc.
  • Morria Biopharmaceuticals Plc
  • Maruho Co.,Ltd.
  • Pharis Biotec GmbH
  • Kemin Industries, Inc.
  • Interprotein Corporation
  • Mimetica Pty Ltd.
  • Celtic Pharmaceutical Holdings L.P.
  • Immune Technologies and Medicine
  • Mantecorp Industria Quimica e Farmaceutica Ltda
  • EMS S.A.

For more information visit http://www.researchandmarkets.com/research/2d9aaf13/dermatitis_pipel

Source: Global Markets Direct

Business Wire
http://www.businesswire.com/

Last updated on: 11/04/2012

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.